Stifel Nicolaus Restarts Ocera Therapeutics (OCRX) at Buy

December 30, 2013 7:29 AM EST Send to a Friend
Get Alerts OCRX Hot Sheet
Price: $5.63 -1.4%

Rating Summary:
    4 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 13 | New: 4
Trade OCRX Now!
Join SI Premium – FREE
Stifel Nicolaus reinstates Ocera Therapeutics (Nasdaq: OCRX) at Buy and price target of $19.

For an analyst ratings summary and ratings history on Ocera Therapeutics click here. For more ratings news on Ocera Therapeutics click here.

Shares of Ocera Therapeutics closed at $11.70 last Fridy.




You May Also Be Interested In


Related Categories

Analyst PT Change, New Coverage

Related Entities

Stifel Nicolaus

Add Your Comment